Mechanism of this protective effect against BE may be through the inhibition of cyclooxygenase-2 (COX-2) and nuclear factor kappa-B (NF-κB) pathway which can be activated by pro-inflammatory cytokines including TNF-α41,42. The gene discussed is PTGS2; the disease is Barrett esophagus.